CELESTICA INC (CLS.CA) Stock Fundamental Analysis

TSX:CLS • CA15101Q2071

381.72 CAD
+8.1 (+2.17%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Taking everything into account, CLS scores 6 out of 10 in our fundamental rating. CLS was compared to 15 industry peers in the Electronic Equipment, Instruments & Components industry. CLS has an excellent profitability rating, but there are some minor concerns on its financial health. CLS is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make CLS a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • CLS had positive earnings in the past year.
  • In the past year CLS had a positive cash flow from operations.
  • CLS had positive earnings in each of the past 5 years.
  • Each year in the past 5 years CLS had a positive operating cash flow.
CLS.CA Yearly Net Income VS EBIT VS OCF VS FCFCLS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • CLS's Return On Assets of 11.54% is amongst the best of the industry. CLS outperforms 100.00% of its industry peers.
  • With an excellent Return On Equity value of 37.56%, CLS belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • The Return On Invested Capital of CLS (24.36%) is better than 100.00% of its industry peers.
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROIC 24.36%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLS.CA Yearly ROA, ROE, ROICCLS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • With a decent Profit Margin value of 6.72%, CLS is doing good in the industry, outperforming 80.00% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CLS has grown nicely.
  • The Operating Margin of CLS (7.80%) is better than 80.00% of its industry peers.
  • In the last couple of years the Operating Margin of CLS has grown nicely.
  • CLS's Gross Margin of 12.06% is on the low side compared to the rest of the industry. CLS is outperformed by 80.00% of its industry peers.
  • In the last couple of years the Gross Margin of CLS has grown nicely.
Industry RankSector Rank
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
CLS.CA Yearly Profit, Operating, Gross MarginsCLS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CLS is creating value.
  • CLS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CLS.CA Yearly Shares OutstandingCLS.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CLS.CA Yearly Total Debt VS Total AssetsCLS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • CLS has a debt to FCF ratio of 1.69. This is a very positive value and a sign of high solvency as it would only need 1.69 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.69, CLS belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
  • A Debt/Equity ratio of 0.34 indicates that CLS is not too dependend on debt financing.
  • CLS has a worse Debt to Equity ratio (0.34) than 60.00% of its industry peers.
  • Even though the debt/equity ratio score it not favorable for CLS, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Altman-Z N/A
ROIC/WACC2.75
WACC8.85%
CLS.CA Yearly LT Debt VS Equity VS FCFCLS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.44 indicates that CLS should not have too much problems paying its short term obligations.
  • CLS's Current ratio of 1.44 is in line compared to the rest of the industry. CLS outperforms 46.67% of its industry peers.
  • CLS has a Quick Ratio of 1.44. This is a bad value and indicates that CLS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.88, CLS perfoms like the industry average, outperforming 46.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.88
CLS.CA Yearly Current Assets VS Current LiabilitesCLS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 54.59% over the past year.
  • Measured over the past years, CLS shows a very strong growth in Earnings Per Share. The EPS has been growing by 43.67% on average per year.
  • Looking at the last year, CLS shows a very strong growth in Revenue. The Revenue has grown by 28.46%.
  • The Revenue has been growing by 16.61% on average over the past years. This is quite good.
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%

3.2 Future

  • Based on estimates for the next years, CLS will show a very strong growth in Earnings Per Share. The EPS will grow by 33.06% on average per year.
  • Based on estimates for the next years, CLS will show a very strong growth in Revenue. The Revenue will grow by 28.15% on average per year.
EPS Next Y38.59%
EPS Next 2Y37.93%
EPS Next 3Y33.06%
EPS Next 5YN/A
Revenue Next Year32.94%
Revenue Next 2Y32.93%
Revenue Next 3Y28.15%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLS.CA Yearly Revenue VS EstimatesCLS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B 25B
CLS.CA Yearly EPS VS EstimatesCLS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • CLS is valuated quite expensively with a Price/Earnings ratio of 46.21.
  • 86.67% of the companies in the same industry are more expensive than CLS, based on the Price/Earnings ratio.
  • CLS is valuated expensively when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 33.35, CLS can be considered very expensive at the moment.
  • 93.33% of the companies in the same industry are more expensive than CLS, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, CLS is valued at the same level.
Industry RankSector Rank
PE 46.21
Fwd PE 33.35
CLS.CA Price Earnings VS Forward Price EarningsCLS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CLS is valued cheaply inside the industry as 86.67% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, CLS is valued a bit cheaper than the industry average as 73.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 70.23
EV/EBITDA 28.35
CLS.CA Per share dataCLS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100

4.3 Compensation for Growth

  • CLS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CLS has a very decent profitability rating, which may justify a higher PE ratio.
  • CLS's earnings are expected to grow with 33.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.2
PEG (5Y)1.06
EPS Next 2Y37.93%
EPS Next 3Y33.06%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CLS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CELESTICA INC

TSX:CLS (2/13/2026, 7:00:00 PM)

381.72

+8.1 (+2.17%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)01-28
Earnings (Next)04-22
Inst Owners73.66%
Inst Owner ChangeN/A
Ins Owners0.59%
Ins Owner ChangeN/A
Market Cap43.86B
Revenue(TTM)12.39B
Net Income(TTM)832.50M
Analysts81.11
Price Target370.26 (-3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.27%
Min EPS beat(2)5.95%
Max EPS beat(2)6.6%
EPS beat(4)4
Avg EPS beat(4)7.73%
Min EPS beat(4)5.95%
Max EPS beat(4)11.71%
EPS beat(8)8
Avg EPS beat(8)9.02%
EPS beat(12)12
Avg EPS beat(12)8.99%
EPS beat(16)16
Avg EPS beat(16)8.6%
Revenue beat(2)2
Avg Revenue beat(2)4.43%
Min Revenue beat(2)3.86%
Max Revenue beat(2)5%
Revenue beat(4)4
Avg Revenue beat(4)4.69%
Min Revenue beat(4)2.5%
Max Revenue beat(4)7.4%
Revenue beat(8)7
Avg Revenue beat(8)3.75%
Revenue beat(12)11
Avg Revenue beat(12)3.24%
Revenue beat(16)15
Avg Revenue beat(16)3.66%
PT rev (1m)6.5%
PT rev (3m)37.43%
EPS NQ rev (1m)14.01%
EPS NQ rev (3m)14.81%
EPS NY rev (1m)0%
EPS NY rev (3m)0.76%
Revenue NQ rev (1m)10.4%
Revenue NQ rev (3m)12.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.61%
Valuation
Industry RankSector Rank
PE 46.21
Fwd PE 33.35
P/S 2.6
P/FCF 70.23
P/OCF 48.81
P/B 14.52
P/tB 19.91
EV/EBITDA 28.35
EPS(TTM)8.26
EY2.16%
EPS(NY)11.45
Fwd EY3%
FCF(TTM)5.43
FCFY1.42%
OCF(TTM)7.82
OCFY2.05%
SpS146.94
BVpS26.28
TBVpS19.18
PEG (NY)1.2
PEG (5Y)1.06
Graham Number69.89
Profitability
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROCE 29.51%
ROIC 24.36%
ROICexc 29.78%
ROICexgc 38.37%
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
FCFM 3.7%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
F-Score7
Asset Turnover1.72
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Debt/EBITDA 0.66
Cap/Depr 114.51%
Cap/Sales 1.62%
Interest Coverage 17.86
Cash Conversion 57.76%
Profit Quality 55.05%
Current Ratio 1.44
Quick Ratio 0.88
Altman-Z N/A
F-Score7
WACC8.85%
ROIC/WACC2.75
Cap/Depr(3y)107.56%
Cap/Depr(5y)87.85%
Cap/Sales(3y)1.66%
Cap/Sales(5y)1.48%
Profit Quality(3y)69.38%
Profit Quality(5y)101.2%
High Growth Momentum
Growth
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
EPS Next Y38.59%
EPS Next 2Y37.93%
EPS Next 3Y33.06%
EPS Next 5YN/A
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%
Revenue Next Year32.94%
Revenue Next 2Y32.93%
Revenue Next 3Y28.15%
Revenue Next 5YN/A
EBIT growth 1Y69.46%
EBIT growth 3Y58.27%
EBIT growth 5Y54.91%
EBIT Next Year55.75%
EBIT Next 3Y35.82%
EBIT Next 5YN/A
FCF growth 1Y51.25%
FCF growth 3Y34.37%
FCF growth 5Y19.66%
OCF growth 1Y39.16%
OCF growth 3Y30.33%
OCF growth 5Y22.45%

CELESTICA INC / CLS.CA FAQ

Can you provide the ChartMill fundamental rating for CELESTICA INC?

ChartMill assigns a fundamental rating of 6 / 10 to CLS.CA.


What is the valuation status of CELESTICA INC (CLS.CA) stock?

ChartMill assigns a valuation rating of 6 / 10 to CELESTICA INC (CLS.CA). This can be considered as Fairly Valued.


What is the profitability of CLS stock?

CELESTICA INC (CLS.CA) has a profitability rating of 7 / 10.


What is the valuation of CELESTICA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CELESTICA INC (CLS.CA) is 46.21 and the Price/Book (PB) ratio is 14.52.


How financially healthy is CELESTICA INC?

The financial health rating of CELESTICA INC (CLS.CA) is 5 / 10.